http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108640841-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P7-625 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C69-732 |
classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-66 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-732 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P7-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
filingDate | 2018-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-108640841-B |
titleOfInvention | Depside cyclic ether compound and preparation method and application thereof |
abstract | The invention discloses a depside cyclic ether compound, which has a structural formula shown in formula 1: the inventor occasionally isolated the above-mentioned cyclic ether-depsides when isolating the fermentation product of Aspergillus unguiculatus 6-20-6, a mutagenic strain of the marine fungus Aspergillus talus. Experiments prove that the depside cyclic ether compound has the effects of inhibiting pseudomonas aeruginosa, methicillin-resistant staphylococcus aureus and candida albicans, and can be used for preparing antibacterial agents or antifungal agents. |
priorityDate | 2018-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 78.